European Urology

Article	Citations
Re: Immune Contexture Changes Following Blue Light Cystoscopy with Hexaminolevulinate in Bladder Cancer	1172
Manfred Wirth – A life devoted to urology in a time of change	1126
Editorial Board	653
The Platinum Hall of Fame	575
More Than Words: Defining Adjuvant, Consolidative, and Salvage Treatment after Radical Prostatectomy	560
Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration: Results from the PROOF302 Phase 3 Trial	533
Honing Stratification and Treatment for High-risk Prostate Cancer	401
Re: Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma	391
Re: Carlotta Nedbal, Patrick Juliebø-Jones, Eamonn Rogers, et al. Improving Patient Information and Enhanced Consent in Urology: The Impact of Simulation and Multimedia Tools. A Systematic Literature	337
Editorial Board	333
Prostate Cancer Active Surveillance Without Biopsy? Not Quite Yet, but Watch This Space	253
Reply to Nour Khalil, Guiseppe Maiolino, and Eric Barret’s Letter to the Editor re: Rui M. Bernardino, Theodorus van der Kwast, Neil E. Fleshner. Intraductal Carcinoma and Cribriform Pattern in Prosta	246
Do women choose urology residency as much as men? Female urology resident representation in Spain in the last decade	230
Development and validation of a new personalized algorithmic model for PSA analysis : PROSTia	202
Re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential	189
Reply to Felix Melchior, Andreas Pircher, and Isabel Heidegger’s Letter to the Editor re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinica	182
Re: Local Anaesthetic Transperineal Biopsy Versus Transrectal Prostate Biopsy in Prostate Cancer Detection (TRANSLATE): A Multicentre, Randomised, Controlled Trial	173
Re: Marcio Covas Moschovas, Shady Saikali, Marco Sandri, et al. Outcomes of Salvage Robotic-assisted Radical Prostatectomy: High-volume Multicentric Data from the European Association of Urology Robot	169
Reply to Jonas Hugosson. Population-based Screening for Prostate Cancer: Is It Time? Eur Urol. 2025;87:340–341	161
Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin–unresponsive Carcinoma in Situ of the Bladder	156
Re: W. Marston Linehan, Cathy Anne Pinto, Yanfang Liu, et al. Longitudinal Evaluation of Clear-cell Renal Cell Carcinoma in von Hippel-Lindau Disease. Eur Urol 2025;88:56–63	156
Acknowledgement to Reviewers	142
Re: Duration of Androgen Deprivation Therapy with Postoperative Radiotherapy for Prostate Cancer: A Comparison of Long-course Versus Short-course Androgen Deprivation Therapy in the RADICALS-HD Random	135
Pembrolizumab Retreatment in Patients with Advanced or Metastatic Urothelial Carcinoma Who Responded to First-course Pembrolizumab-based Therapy	126
Reply to Laurence Klotz’s Letter to the Editor re: Jeremy Yeun-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of “Manels” in Major Urology	126

Delayed absent ejaculation in men presenting to the fertility clinic – retrospective cohort study	121
Congress Calendar	120
SWL is more cost-effective than fURS for the management of kidney stones: Comparative study in a tertiary care centre	117
The impact of adjuvant chemotherapy on overall survival in patients with node-positive Upper Tract Urothelial Carcinoma (UTUC): Improving precision in medicine with a risk-stratified approach	114
Comparing urine and stone microbiome in urolithiasis patients	113
Re: Association of Black Race with Prostate Cancer–specific and Other-cause Mortality	105
A randomized controlled trial comparing 1470nm diode laser vs. plasmakinetic enucleation of the prostate for treating benign prostatic hyperplasia	104
Prostatic artery embolization compared to trans-urethral resection of the prostate and prostatic urethral lift: A real-world population-based study	104
Utility of robotic platform for upper and mid ureteric reconstruction: Our experience at MPUH, Nadiad	102
The use of abdominal drain after robot-assisted surgery in urology: Impact on postoperative pain	99
The complications of synthetic mid-urethral slings: The discrepancy between demographic data and clinical trials- a systematic review with meta-analysis	99
Hsa_circ_0005221 promotes prostate cancer progression through miR-339-5p/ STAT5a	98
Intravesical injection with abobotulinumtoxin-A in patients with bladder pain syndrome/ interstitial cystitis	98
Gender disparities in editorial board of academic urology journals	96
Efficacy of tamsulosin versus mirabegron for ureteric stent related symptoms: Prospective randomized questionnaire based comparison	92
Spontaneous passage rate of ureteral stones and predictive factors after pre-stenting	91
First clinical experience with a novel approach of robot-assisted completely retroperitoneal nephroureterectomy with bladder cuff	89
Comparison of clinical outcomes after phalloplasty with versus without urethral lengthening in transgender men	88
The surgical learning curve for cancer control after robot-assisted radical prostatectomy	87
The feasibility and advantages of an at-home intravesical therapy service for benign conditions	85
Management of renal cell carcinoma in transplant kidney: An individual patient data meta-analysis and evidence-based guide	84
Evaluation of the effect of umbilical cord derived urethral slings in bilateral pudendal nerves injury-induced urinary incontinence in female rats	82
Do patients prefer telecommunication to traditional face-to face clinic review: A benefit of covid-19?	81
Outcomes according to histological variants of urothelial carcinoma after neoadjuvant chemotherapy in the GETUG-AFU V05 VESPER trial	77
Efficacy of recombinant Bacillus Calmette-Guérin–dltA in three-dimensional bioprinted bladder cancer-on-a-chip with microfluidic system	76
The effect of duration between sessions on biofeedback treatment in children with dysfunctional voiding	75
Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution	75
The international bladder cancer group intermediate-risk non-muscle invasive bladder cancer (IBCG IR-NMIBC) scoring system predicts the need for intervention for patients on active surveillance	74
Salvage focal ablation versus radical prostatectomy for localized radiorecurrent prostate cancer: A propensity-score matched comparison	74
The next generation trial: Assessing 18F-PSMA-1007 positron emission tomography and magnetic resonance imaging in the primary staging of prostate cancer patients	74
Persistently elevated urinary inflammatory biomarkers may predict recurrence of recurrent urinary tract infection in women	74
Impact of systemic therapy in clinical T1 small-cell neuroendocrine carcinoma of the bladder	73
Prospective randomized comparison of SP TFL and Ho:YAG in RIRS for kidney stones: a single-center study	72
Validation of a simplified prognostic model for survival in patients with extrinsic malignant ureteral obstruction treated with tandem ureteral stents	72
Quality and Quantity: Evaluating Tumor Biology Alongside Novel Imaging on Diagnosis of Metastatic Hormone-sensitive Prostate Cancer	72
Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study	70
Putting Precision Medicine in Prostate Cancer into Practice: Are We There Yet?	69
Robot-assisted radical prostatectomy for prostate cancer: 18-year oncological outcomes from a Belgian high-volume center	68
Which men with cN1 prostate cancer at PSMA PET/CT represent the ideal candidate for radical prostatectomy? Development of a novel risk stratification tool for individualized approaches based on a larg	67
Transcriptomic analysis of the lncRNA-miRNA-mRNA axis network in aldosterone-producing adenoma	65
100 years of history-making urology – the Portuguese urology association	64
Incontinence in boys and girls following succesful primary closure of bladder extrophy: Management with orthotopic ileal neobladder and costruction of anterior intrapelvic neourethra derived from detr	64
Congress Calendar	63
A comprehensive in vitro assessment of thulium fiber laser in soft tissues and stones	62
Igloo-technique for robotic radical prostatectomy — maximum nerve sparing for early recovery of continence and sexual function	62
Epidemiological outcomes in immunocompromised vs. immunocompetent prostate cancer patients: A systematic review, meta-analysis and meta-regression	62
Editorial Board	62
Outcomes of urethroplasty (UP), 10 years after surgery	62
Re: Unplanned Conversion from Partial to Radical Nephrectomy: An Analysis of Incidence, Etiology, and Risk Factors	62
Qualitative assessment of patient-reported outcomes in urinary and sexual function in patient after perineal urethrostomy	61

Development of an individual postoperative prediction model for kidney cancer recurrence using machine learning (UroCCR study 120)	60
Rezūm water vapour therapy (Rezūm): Is it safe to continue antiplatelet or anticoagulation medication?	60
Surgical and oncologic outcomes of surgery in early metastatic seminoma: Multi-institutional retrospective study	60
Cumulative thulium fiber laser energy and stone-free rates: Outcomes from the team of worldwide endourological researchers (TOWER) thulium fiber laser registry	60
Surgical outcomes of robot-assisted radical prostatectomy with the novel HUGO™ robotic system: Initial 100 cases performed at a tertiary referral robotic center	59
Protein-based molecular subtypes associate with clinical-pathological characteristics in a multi-institutional cohort of upper tract urothelial carcinomas	59
Propensity-score matched survival analysis of octogenarians with muscle-invasive bladder cancer: Chemoradiation compared to radical cystectomy	58
The development of a hollow three-dimensional kidney spheroid model for the study of calcium-containing crystal formation	58
Contents	58
Improved survival in contemporary actively treated community-based metastatic clear-cell renal cell carcinoma patients	57
Patient-derived organoids represent intra- and interindividual heterogeneity in castration-resistant prostate cancer	57
Prostate cancer prevention clinic for men with risk of familial prostate cancer (profam-risk)	57
Re: Bhavan P. Rai, José Luis Dominguez Escrig, Luís Vale, et al. Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria.	57
Efficacy and safety of darolutamide in combination with androgen-deprivation therapy and docetaxel in European patients from the phase 3 ARASENS trial	56
The Platinum Hall of Fame	55
Single-port vs. multi-port robot-assisted partial nephrectomy: A single center propensity-score matched analysis	55
Efficacy and safety of low-dose tadalafil compared to tolterodine and placebo in females with overactive bladder symptoms. A prospective double blind controlled study	55
Use cluster analysis to develop an accurate and practical diagnostic method for detrusor underactivity in female patient without bladder outlet obstruction	54
Sutureless robot assisted partial nephrectomy: Feasibility and surgical technique (UroCCR n°158)	54
AI-based classification and segmentation method for bladder cancer from cystoscopic image: Preliminary study	53
Impact of radical prostatectomy on pelvic floor muscles: An electromyography and perineometric assessment	53
Multi-centre study comparing outcomes of RIRS using traditional suction ureteral access sheath (SUAS) and flexible-navigable suction UAS (FANS)	52
Retzius-sparing robot-assisted radical prostatectomy for large prostate volumes: Surgical and functional outcomes	52
Re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination The	51
Comparison of two different approaches in the management of infants with primaryobstructive megaureters and their long-term outcomes	51
Association between age and efficacy of first-line immunotherapy-based combination therapies for mRCC: A meta-analysis	50
Short-term morbidity and long-term functional outcomes of the T-plasty for salvage reconstruction of recalcitrant bladder neck stenosis	50
Head to head comparison between RENAL and PADUA nephrometry scores in predicting TRIFECTA achievement in off-clamp Robot-assisted partial nephrectomy	49
Guidewire-marking before robotic salvage lymph node dissection for in-field lymph node recurrences after radical prostatectomy: Initial experiences	48
Non-infectious adverse events of transperineal prostate biopsies performed under local anesthesia in an outpatient setting – results from the NORAPP study – a randomized clinical trial	48
Real-world cost for first-line treatment for prostate cancer: A comparative cost analysis in the public sector	48
Minimally invasive adrenalectomy for the treatment of malignant adrenal metastasis: Results from two high volume centers	47
Orificial surgery at the turn of the 20th century: Not exactly a precursor of current NOTES, but another embarrassing chapter in the history of modern surgery	47
Robot-assisted video-endoscopic radical inguinal lymphadenectomy for penile cancer: surgical anatomy and technique	47
Radiomics model to predict teratoma in metastatic non-seminomatous testicular germ cell tumors	46
Urolithiasis in patients with kidney transplantation: Multicenter KSER research series	46
3D laparoscopic versus robot assisted laparoscopic prostatectomy, a randomized prospective study. Preliminary 1-year functional results	45
First-in-human experience with the LithoVueTM elite single use ureteroscope: Can intrarenal pressure be manipulated?	45
Re: Chen Dong, Sung-Lang Chen, and Wen-Wei Sung’s Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome:	45
Strengths and weaknesses of using Optum Clinformatics Data Mart to study in-vitro fertilization	45
Functional and endoscopic results up to two years after Aquablation for BPH-related LUTS: A single centre first clinical experience	45
Contents	44
Fosfomycin for antibiotic prophylaxis in men undergoing a transrectal prostate biopsy: A systematic review and meta-analysis	44
Clinicopathological correlate of urine 8-hydroxydeoxyguanosine levels in patients with prostate biopsy	44
Minimally invasive cytoreductive nephrectomy for metastatic renal cell carcinoma in the immunotherapy era: Results from the REMARC-IO database	44
Prenatal exposure to SSRI antidepressants and time of neonatal first void - A case control study	43
Bladder EpiCheck methylation test predicts short- and long-term HG events in bladder cancer patients treated with bacillus Calmette-Guérin	43
MRI/US fusion targeted prostate biopsies koelis®: Impact of operator experience on clinicaly significant prostate cancer detection	42
Radiomics-based prognostic model guided by artificial intelligence to predict lymph node invasion and biochemical recurrence in patients with high-grade prostate cancer	42
De-escalation of monitoring for prostate cancer active surveillance: Results of the GAP3 consortium	42
Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials	41
Immunoprophyaxis with MV-140 is effective in the prevention of urinary tract infections – results of a prospective study	41
Mechanism of cystine stone growth revealed by ultrastructural observation using scanning electron microscopy	40
LEST: Anatomical ablative ejaculation sparing surgery for BPH	40
Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma	40
What are the optimal laser settings for stone dusting using the popcorn technique	40
Re: Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes	39
Prognostic impact of clear cell renal cell carcinoma molecular subtypes determined on formalin-fixed paraffin-embedded tissue samples on outcome after complete surgical metastasectomy	39
Aberrant Splice Variants: A Novel Characterization of Clear Cell Renal Cell Carcinoma	38
Inter-reader agreement of the Prostate Imaging Quality (PI-QUAL) scoring system: A two-reader, two-centre study	38
Incremental value of machine learning-based radiomics for preoperative discrimination between malignant and benign small renal masses	38
Risk factors for postoperative infections after urological surgery: Preliminary results from the national and multicenter TOCUS study	38
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups	37
Assessing the potential of cystatin 4 as a blood biomarker for prostate cancer diagnosis and prognosis: A prospective single-center study	36
Is testosterone replacement therapy effective and safe even for eugonadal men with symptom of late onset hypogonadism?	36
Re-treatment for Lower Urinary Tract Symptoms (LUTS) after water vapor thermal therapy	36
Erogenous and aversive sensation throughout the vulva, vagina, and breasts in cis-gender women: Anatomic heat-map to assess effect of treatment on erogenous sensation	36
Incidental prostate cancer in patients treated for benign prostatic hyperplasia: Analysis from a contemporary national dataset	35
Quantitative MRI parameters providing the novel value in discriminating muscle-invasive bladder cancer	35
More micrometastases, more recurrence? Assessing the role of quantitative rtPCR of PSA from lymph nodes post-prostatectomy in predicting biochemical recurrence - an experimental study	35
Reclassification of small renal masses according to the EAU Guidelines newly-proposed TNM classification for suspected renal cell carcinoma: Implications for decision-making	35
Prognostic value of circulating tumor cells and cell-free DNA in upper tract urothelial carcinoma	35
Re: Loren K. Mell, Stephanie L. Pugh, Christopher U. Jones, et al. Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase	34
Photodynamic diagnosis (PDD) directed biopsies vs white light bladder mapping in patients with positive cytology and negative preoperative workup: An international multicenter retrospective study. On	34
Lawton instrumental activities of daily living scale identifies patients at high-risk of adverse outcomes after kidney surgery for renal cancer: A prospective clinical study	34
Prostatectomy vs. radiotherapy for regional node positive prostate cancer	34
What is new at the deepest point of human civilization for andrologic point of view?	33
Replacing ReTUR with Cystoscopy in High-Grade T1 NMIBC patients: Confirmatory results from the HuNIRe Trial	33
Comparing PSA screening patterns and their role as predictor of prostate cancer incidence and mortality: A system wide analysis of a contemporary North American cohort	32
Efficacy of sacral nerve modulation in the treatment of neurogenic overactive bladder in patients with multiple sclerosis	32

Epidermal growth factor-like domain 7 inhibit immune response in metastatic castration resistant prostate cancer by de-activation of endothelial intercellular adhesion molecule-1	32
Re: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association	31
A0347 – The genotype-phenotype association in von Hippel-Lindau (VHL) disease with the codon 167 missense mutations: A large retrospective study/a population-based study	31
Re: The Prognostic Value of p53 and Ki-67 Expression Status in Penile Cancer: A Systematic Review and Meta-analysis	31
Re: Nicolas Demogeot, Paul Sargos, Julia Salleron, et al. Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the	31
Re: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Cu	31
Re: Baris Turkbey, Henkjan Huisman, Andriy Fedorov, et al. Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naïve Men: PI-RADS Steering Committee, Version 1.0.	31
Re: Adjuvant Atezolizumab Versus Placebo for Patients with Renal Cell Carcinoma at Increased Risk of Recurrence Following Resection (IMmotion010): A Multicentre, Randomised, Double-blind, Phase 3 Tria	31
P213 – The influence of STAT1 butyrylation in the prostate transition zone on benign prostatic hyperplasia via the NOTCH1/ATF3 pathway	30
P266 – From stones to strokes: How calcium kidney stones signal carotid atherosclerosis through oxidative stress	30
A0866 – A randomized, open-label, controlled clinical study to assess the digital health application INKA in the management of therapy refractory overactive bladder and mixed incontinence	30
A0759 – Vecto® prostate biopsy: 4-year outcomes of novel MRI-US fusion, transperineal prostate biopsies under local anaesthesia, utilising electromagnetic needle tracking	30
P547 – Genomic insights into intraductal carcinoma of the prostate from the Genomic Umbrella Neoadjuvant Study (GUNS) in high-risk localized prostate cancer	30
A0078 – IP8-FLUORESCE: A prospective paired-cohort study evaluating fluorescence confocal microscopy for rapid evaluation of surgical margins in radical prostatectomy	30
A0519 – Efficacy and tolerability of androgen receptor targeted agents (ARTAs) in patients with metastatic castration-resistant prostate cancer (mCRPC) in different treatment sequences	30
P203 – Systemic immune inflammation and stress urinary incontinence	29
P639 – Site-specific differences of eligibility for adjuvant immunotherapy among urothelial carcinoma patients treated with radical surgery: Results of a multicenter cohort study	29
A0486 – Comparison of 1-mm vs. 0.5-mm thick reconstructed images to evaluate residual stone fragments and dust particles: An evaluation using porcine kidneys	29
A0796 – Cost-effectiveness analysis of treatments for BCG-unresponsive high-risk NMIBC	29
A0100 – Day care PCNL: Who Qualifies? Introducing the day-care PCNL checklist	28
P393 – Identification, validation and pathway enrichment analysis of differentially expressed genes and miRNAs as diagnostic biomarkers in clear cell renal cell carcinoma	28
P082 – Age disparity in couples seeking first medical help for infertility has changed over the last twenty years: A sociological study	28
A0611 – Prediction of prostate cancer biochemical recurrence by a specific collagen-related proteo-transcriptomics signature	28
A0459 – Is there an oncological benefit of extended pelvic lymph node dissection at the time of radical prostatectomy in PSMA-PET node negative prostate cancer patients? Results from a multi-instituti	28
A0228 – A randomized controlled trial comparison of stent-related symptoms between anti-reflux stents and standard double-J stents in school-age children	28
P033 – Is the routine histological analysis of paediatric foreskin specimens following a circumcision justified?	28
A0677 – Bladder EpiCheck triggered photodynamic diagnosis biopsies detect high grade recurrences missed by white light cystoscopy	28
A0248 – Natural and assisted conceptions in young men treated for hematological cancer who stored their semen for fertility preservation	27
A0276 – OPUS program: Organized prostate cancer screening in Mexico	27
A0634 – Evaluation of Salvage High Intensity Focused Ultrasound (S-HIFU) and hemi-S-HIFU for radiorecurrent prostate cancer	27
V115 – Management of pelvic vessels injury during robotic pelvic urooncology procedures	27
A0546 – The diagnostic potential of the penile cavernous density measurement by ultrasound	27
A0321 – Definition of risk categories for urethral stricture recurrence after free graft bulbar urethroplasty using classification and regression tree analysis	26
GC6 – Micro-ultrasound-guided versus MRI-guided biopsy for prostate cancer diagnosis (OPTIMUM trial)	26
A0622 – Single-port nerve-sparing radical prostatectomy – initial learning curve of a high-volume multi-port surgeon	26
A0607 – What is the optimal BCR-free survival cut-off predicting favourable long-term outcomes? A multicenter retrospective EMPaCT study	26
P410 – Perioperative and oncological outcomes of incomplete thermal ablations with or without immediate retreatment for patients with small renal masses	26
P369 – Predictors of intraoperative conversion from robotic to open radical cystectomy and effects on patients survival	26
A0872 – Real-world experience and long-term survival of high-risk non-muscle invasive bladder cancer treated with BCG: 5-year outcomes from a large UK tertiary referral centre	26
P505 – The role of prostate-specific antigen after cryotherapy for primary localized prostate cancer	26
P190 – The impact of radiographic disappearance of metastases as a new surrogate marker for therapy in patients with metastatic hormone-sensitive prostate cancer	25
A0492 – Adopting stone volume instead of maximum stone diameter: Worth it or an academic fantasy? Results from a worldwide survey	25
A0484 – Endourology clinic: Artificial intelligence vs. natural intelligence	25
P219 – The quality of life of pregnant patients after active and delayed endourological treatment of urolithiasis	25
P225 – Effect of preoperative urine culture timing on postoperative outcomes of retrograde intrarenal surgery: Preliminary results of the RIRSearch study	25
P526 – Single port versus multiport robotic nephroureterectomy with bladder cuff exicision: Comparative study for initial cases	25
Ischemia Time Has Little Influence on Renal Function Following Partial Nephrectomy: Is It Time for Urology to Stop the Tick-Tock Dance?	25
A0150 – Enrolment of racial and ethnic minority group patients in contemporary non-prostate cancer urological clinical trials: A systematic review	25
A0493 – Updated meta-analysis of VI-RADS score in image-guided assessment of muscle invasiveness in bladder cancer Pre-TURBT	25
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 4: Transperineal Magnetic Resonance–Ultrasound Fusion Guided	25
Corrigendum to “Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [177Lu]Lu-PSMA-617 in the Ph	24
Re: Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis	24
Prostate-Specific Antigen Screening in Transgender Patients	24
Contents	24
European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update	24
Robotic Bladder Auto-transplantation in a Heart-beating Brain-dead Human Research Donor	24
Tumors of the Urinary System and Male Genital Organs: 2022 World Health Organization Classification and Multidisciplinarity	24
18F-PSMA-11 as an Attractive 68Ga-PSMA-11 Alternative for Prostate Cancer Imaging	24
A prospective paired comparison trial on mirabegron and anticholinergics in patients with low bladder compliance	24
Re: Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients with Localized Prostate Cancer: Results from the FLAME Randomized Phase III Trial	23
Re: Massimiliano Creta, Giorgio I. Russo, Naeem Bhojani, et al. Bladder Outlet Obstruction Relief and Symptom Improvement Following Medical and Surgical Therapies for Lower Urinary Tract Symptoms Sugg	23
Re: Nicolaus F. Debatin, Elena Bady, Tim Mandelkow, et al. Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial Cancer. Eur Urol. 2024;86:42–51	23
A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-Guérin Response in Non–muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial	23
Re: A New Technique for the Treatment of Ureteric Stricture After Kidney Transplantation	22
Congress Calendar	22
Comparison between long-term outcomes of low-dose-rate brachytherapy and radical prostatectomy in patients with intermediate-risk prostate cancer: Propensity match scoring analysis	22
Re: Male-partner Treatment to Prevent Recurrence of Bacterial Vaginosis	22
Re: Lucia L. Rijstenberg, Hridya Harikumara, Esther I. Verhoef, et al. Identification of Intraductal-to-Invasive Spatial Transitions in Prostate Cancer: Proposal for a New Unifying Model on Intraducta	22
Usefulness of transperineal ultrasound as a method of membranous urethral length measurement compared to magnetic resonance in men prior to radical prostatectomy	22
Bladder NIRS: A non-invasive method functional to distinguish between detrusor underactivity (DU) and Bladder Outlet Obstruction (BOO) in men with LUTS	22
Refining the Tissue Source for Biomarker-based Approaches in Renal Cell Carcinoma	22
Dynamic compression of the urethra – mechanism of action of a male transobturator sling with 5-year imaging follow-up	22
Efficacy of topical triamcinolone for intermittent catheterization following internal urethrotomy: A systematic review and meta-analysis of randomized controlled trials	21
Challenging the dogma: Should unilateral pelvic lymph node dissection be envisioned in the multiparametric prostate MRI era?	21
Outcomes of penile cancer stratified by nodal staging: Importance of pelvic nodal involvement	21
Development of a novel diagnostic model for urological cancers using comprehensive N-glycan signatures of serum immunoglobulins with a machine learning approach	21
Re: The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) Reg	21
Expanding the use of targeted therapy for Urothelial Bladder Cancer (UBC): Non-FGFR3 Receptor Tyrosine Kinase (RTK) Gene Rearrangements (ReAr) and Fusions (Fus)	21
Vector prostate biopsy: A novel electro-magnetic biopsy technique for mpMRI/US fusion transperineal prostate biopsies under local anaesthesia	21
Health-related quality of life following cytoreductive radical prostatectomy in patients with de-novo oligometastatic prostate cancer	20
Inflammatory chemokines upregulated in the tumor microenvironment of prostate cancer patients experiencing relapse after radical prostatectomy	20
Oncological outcomes in patients with recurrent prostate cancer staged with PSMA PET/CT: Results from 3 European tertiary centers	20
Mirabegron and Solifenacin in treatment of primary nocturnal enuresis with reduced nocturnal bladder capacity: A randomized double blind placebo controlled study	20
Safety and efficacy of personalized LND vs. ePLND during radical prostatectomy. Personalympca: A randomized phase II study	20
Use of allium ureteral stents for managing iatrogenic ureteric injuries	19
Epigenetic dysregulation of tumor suppressor genes in cp⁄cpps: Studies on liquid biopsies for biomarker development	19
Editorial Board	19
Systematic definition of treatment modality and clinical outcomes reporting system in case of surgical treatment for Von Hippel-Lindau renal cell carcinoma	19
Do French urologists suffer from imposter syndrome? A survey	19
Variability in diagnostic performance of non-muscle invasive bladder cancer for each region using fluorescence cystoscopy with orally administered 5-aminolevulinic acid	19
Protective effect of LCZ696 on kidney function after partial nephrectomy	18
Endoscopic treatment of parapelvic renal cysts	18
Perinephric toxic fat: Impact on surgical complexity, perioperative outcome and surgical approach in partial nephrectomy	18
Feasibility of first postoperative day foley catheter removal after robotic assisted radical prostatectomy	18
Urinary human papilloma virus infection and bladder cancer risk: A systematic review and a prisma-compliant meta-analysis	18